Should be in everyone’s portfolio in my opinion.
Printable View
Should be in everyone’s portfolio in my opinion.
An interesting article behind paywall in the Herald today about pet food maker Ziwi Peak and how there are industry rumours it may sell for over $1B, with operational earnings of $50m. EBOS mentioned in the article as one of the original possible suitors but now Chinese funds have entered the race !!
https://www.nzherald.co.nz/business/...AHWZC53DZO34I/
There have been plenty of rumours about Ziwi for a while, had previously heard $650m a few months ago, but if they have a bidding war going on, good on them. Building a new factory in Napier - think about 12,500 sq metres.
Personally don't think they are for EBOS. Going to pay a large multiple, and only a small amount of Ziwi's sales are in NZ - so not much of a bolt-on to existing business. Although think they do a bit in Australia. Most sales are in markets outside Oceania.
K9 Natural got sold to KKR recently, and would have been a large multiple/goodwill, as K9 don't own their own plants. KKR Acquires Natural Pet Food Group | Business Wire
Going to be a great payday for Mark Stewart (72%) and the remaining Ziwi owners/founders.
might be some movement in share prices coming up this month as the china property market weights on global markets.
giving opportunities for picking up more shares in quality stocks at lower prices.
BlackHawk and Vitapet generated double digit sales growth in FY21 and have continued their strong performance in the first quarter of FY22.
a pleasing start to the FY22 financial year with strong revenue and earnings growth recorded across both our Healthcare and Animal Care segments.For the three months ended 30 September 2021, Group revenue and earnings grew at just over 10% compared to the prior corresponding period
Lock downs and pets are being petted.
Luxury dog hotel on some channel somewhere with a day care centre catering for a full range of dog services and mental health care.
Its a "mystical bond between man and dog (car)" ...Bobby Bolivia.
Liz said We have received positive feedback from the investment community on our first Sustainability Report and I look forward to keeping you updated as we make further progress in this area.
That’s an important statement ……the way investment managers look at ESG things these days that could possibly add a few bucks to the share price over time.
"ESG"
yes some solutions for that dog walk.
triple top now firmly established
possibly test the low of the channel again. (or more - triple tops are often a big deal - though this is only on the hourly)
this picture taken a few days ago when I first noticed it forming. (tho I havent added anything to it - just a clean snap)
Attachment 13184
A bit like an abstract art work and more colourful than scattered tea leaves. What is your interpretation of significance/artists statement peat?
missed seeing your post glennj
so a triple top is a sell but look what its done now, its come back and pierced that high level briefly. oh how confusing! now gone back to test again.
so I see this as pent up pressure now, but clearly direction is still unclear.
But, given its a fantastic stock that is doing well and while priced quite expensively the metrics are somewhat supported by LT growth and quality management I'd consider it more likely to explode upwards.
no position held.
thar she blows
Tradin halt. Placement coming today.
"EBOS Group Limited (EBOS) has entered into a share purchase agreement to acquire LifeHealthcare from Funds advised by Pacific Equity Partners and other minority holders, comprising 100% of LifeHealthcare’s Australian & New Zealand subsidiaries and 51% of LifeHealthcare’s Asian subsidiary, Transmedic (together, LifeHealthcare), for total consideration of approximately A$1,167 million (representing an enterprise value of approximately A$1,275 million on a 100% basis) subject to customary purchase price adjustments (the Acquisition or Transaction).FUNDING
The Acquisition will be fully funded through a combination of the proceeds of a non-underwritten retail offer to eligible existing shareholders to raise up to A$100 million, with the ability to accept oversubscriptions at EBOS’ discretion, approximately A$642 million raised from the Placement, a new A$540 million term loan debt facility and approximately 0.7 million new EBOS shares issued to LifeHealthcare management (approximately $23 million )."